{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:52:41Z","timestamp":1761126761289},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Behcet\u2019s disease (BD) is a relapsing systemic vascular autoimmune\/inflammatory disease. Despite much effort to investigate BD, there are virtually no unique laboratory markers identified to help in the diagnosis of BD, and the pathogenesis is largely unknown. The aim of this work is to explore interactions between different clinical variables by correlation analysis to determine associations between the functional linkages of different paired variables and potential diagnostic biomarkers of BD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We measured the immunoglobulin proteome (IgG, IgG1\u20134, IgA, IgA1\u20132) and 29 clinical variables in 66 healthy controls and 63 patients with BD. We performed a comprehensive clinical variable linkage analysis and defined the physiological, pathological and pharmacological linkages based on the correlations of all variables in healthy controls and BD patients without and with immunomodulatory therapy. We further calculated relative changes between variables derived from comprehensive linkage analysis for better indications in the clinic. The potential indicators were validated in a validation set with 76 patients with BD, 30 healthy controls, 18 patients with Takayasu arteritis and 18 patients with ANCA-associated vasculitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In this study, the variables identified were found to act in synergy rather than alone in BD patients under physiological, pathological and pharmacological conditions. Immunity and inflammation can be suppressed by corticosteroids and immunosuppressants, and integrative analysis of granulocytes, platelets and related variables is likely to provide a more comprehensive understanding of disease activity, thrombotic potential and ultimately potential tissue damage. We determined that total protein\/mean corpuscular hemoglobin and total protein\/mean corpuscular hemoglobin levels, total protein\/mean corpuscular volume, and plateletcrit\/monocyte counts were significantly increased in BD compared with controls (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05, in both the discovery and validation sets), which helped in distinguishing BD patients from healthy and vasculitis controls. Chronic anemia in BD combined with increased total protein contributed to higher levels of these biomarkers, and the interactions between platelets and monocytes may be linked to vascular involvement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>All these results demonstrate the utility of our approach in elucidating the pathogenesis and in identifying novel biomarkers for autoimmune diseases in the future.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12865-021-00403-1","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T20:16:32Z","timestamp":1614024992000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet\u2019s disease patients receiving immunomodulatory treatment"],"prefix":"10.1186","volume":"22","author":[{"given":"Linlin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liubing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liujun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"403_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10067-010-1430-6","volume":"29","author":"F Davatchi","year":"2010","unstructured":"Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Faridar A, Ashofteh F, Sadeghi AB. Behcet's disease: from east to west. Clin Rheumatol. 2010;29:823\u201333.","journal-title":"Clin Rheumatol"},{"key":"403_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","volume":"14","author":"H Yazici","year":"2018","unstructured":"Yazici H, Seyahi E, Hatemi G, Yazici Y. Behcet syndrome: a contemporary view. Nat Rev Rheumatol. 2018;14:107\u201319.","journal-title":"Nat Rev Rheumatol"},{"key":"403_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4419-5641-5_14","volume-title":"Beh\u00e7et\u2019s Syndrome","author":"H Direskeneli","year":"2010","unstructured":"Direskeneli H, Saruhan-Direskeneli G. Disease mechanisms. In: Yaz\u0131c\u0131 Y, Yaz\u0131c\u0131 H, editors. Beh\u00e7et\u2019s Syndrome. New York, NY: Springer New York; 2010. p. 243\u201364."},{"key":"403_CR4","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s10787-019-00567-8","volume":"27","author":"F Djaballah-Ider","year":"2019","unstructured":"Djaballah-Ider F, Djaballah A, Djeraba Z, Chaib S, Touil-Boukoffa C. Auto-immunity profile evaluation during different clinical manifestations of Behcet disease in Algerian patients: effect of corticosteroid treatment. Inflammopharmacology. 2019;27:1113\u201322.","journal-title":"Inflammopharmacology."},{"key":"403_CR5","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/bjd.12128","volume":"168","author":"SB Cho","year":"2013","unstructured":"Cho SB, Zheng Z, Ahn KJ, Choi MJ, Cho S, Kim DY, Lee HS, Bang D. Serum IgA reactivity against GroEL of Streptococcus sanguinis and human heterogeneous nuclear ribonucleoprotein A2\/B1 in patients with Behcet disease. Br J Dermatol. 2013;168:977\u201383.","journal-title":"Br J Dermatol"},{"key":"403_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.rdc.2015.08.004","volume":"42","author":"J Youssef","year":"2016","unstructured":"Youssef J, Novosad SA, Winthrop KL. Infection risk and safety of corticosteroid use. Rheum Dis Clin N Am. 2016;42:157\u201376 ix-x.","journal-title":"Rheum Dis Clin N Am"},{"key":"403_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10787-018-0472-2","volume":"26","author":"F Djaballah-Ider","year":"2018","unstructured":"Djaballah-Ider F, Djeraba Z, Chemli M, Dammene-Debbihe N, Lounis D, Belguendouz H, Medour Y, Chaib S, Touil-Boukoffa C. Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behcet's disease. Inflammopharmacology. 2018;26:725\u201335.","journal-title":"Inflammopharmacology."},{"key":"403_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/annrheumdis-2012-202297","volume":"72","author":"C Bohler","year":"2013","unstructured":"Bohler C, Radner H, Smolen JS, Aletaha D. Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis. Ann Rheum Dis. 2013;72:241\u20134.","journal-title":"Ann Rheum Dis"},{"key":"403_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10067-007-0786-8","volume":"27","author":"H Direskeneli","year":"2008","unstructured":"Direskeneli H, Ergun T, Yavuz S, Hamuryudan V, Eksioglu-Demiralp E. Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease. Clin Rheumatol. 2008;27:373\u20135.","journal-title":"Clin Rheumatol"},{"key":"403_CR10","first-page":"2559","volume":"14","author":"CG Katsiari","year":"2018","unstructured":"Katsiari CG, Simopoulou T, Alexiou I, Sakkas LI. Immunotherapy of systemic sclerosis. Human Vaccines & Immunotherapeutics. 2018;14:2559\u201367.","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"403_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nbt.3870","volume":"35","author":"ND Price","year":"2017","unstructured":"Price ND, Magis AT, Earls JC, Glusman G, Levy R, Lausted C, Mcdonald DT, Kusebauch U, Moss CL, Zhou Y, Qin S, Moritz RL, Brogaard K, Omenn GS, Lovejoy JC, Hood L. A wellness study of 108 individuals using personal, dense, dynamic data clouds. Nat Biotechnol. 2017;35:747\u201356.","journal-title":"Nat Biotechnol"},{"key":"403_CR12","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188793","volume":"15","author":"L Niu","year":"2019","unstructured":"Niu L, Geyer PE, Wewer Albrechtsen NJ, Gluud LL, Santos A, Doll S, Treit PV, Holst JJ, Knop FK, Vilsboll T, Junker A, Sachs S, Stemmer K, Muller TD, Tschop MH, Hofmann SM, Mann M. Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease. Mol Syst Biol. 2019;15:e8793.","journal-title":"Mol Syst Biol"},{"key":"403_CR13","doi-asserted-by":"publisher","first-page":"901","DOI":"10.15252\/msb.20167357","volume":"12","author":"PE Geyer","year":"2016","unstructured":"Geyer PE, Wewer Albrechtsen NJ, Tyanova S, Grassl N, Iepsen EW, Lundgren J, Madsbad S, Holst JJ, Torekov SS, Mann M. Proteomics reveals the effects of sustained weight loss on the human plasma proteome. Mol Syst Biol. 2016;12:901.","journal-title":"Mol Syst Biol"},{"key":"403_CR14","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.7150\/thno.31144","volume":"9","author":"M Xu","year":"2019","unstructured":"Xu M, Deng J, Xu K, Zhu T, Han L, Yan Y, Yao D, Deng H, Wang D, Sun Y, Chang C, Zhang X, Dai J, Yue L, Zhang Q, Cai X, Zhu Y, Duan H, Liu Y, Li D, Zhu Y, Radstake T, Balak DMW, Xu D, Guo T, Lu C, Yu X. In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine. Theranostics. 2019;9:2475\u201388.","journal-title":"Theranostics."},{"key":"403_CR15","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00125-019-4906-1","volume":"62","author":"RW Koivula","year":"2019","unstructured":"Koivula RW, Forgie IM, Kurbasic A, Vinuela A, Heggie A, Giordano GN, Hansen TH, Hudson M, Koopman ADM, Rutters F, Siloaho M, Allin KH, Brage S, Brorsson CA, Dawed AY, De Masi F, Groves CJ, Kokkola T, Mahajan A, Perry MH, Rauh SP, Ridderstrale M, Teare HJA, Thomas EL, Tura A, Vestergaard H, White T, Adamski J, Bell JD, Beulens JW, Brunak S, Dermitzakis ET, Froguel P, Frost G, Gupta R, Hansen T, Hattersley A, Jablonka B, Kaye J, Laakso M, Mcdonald TJ, Pedersen O, Schwenk JM, Pavo I, Mari A, Mccarthy MI, Ruetten H, Walker M, Pearson E, Franks PW. Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium. Diabetologia. 2019;62:1601\u201315.","journal-title":"Diabetologia"},{"key":"403_CR16","first-page":"1078","volume":"335","author":"Criteria for diagnosis of Behcet's disease","year":"1990","unstructured":"Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990;335:1078\u201380.","journal-title":"Lancet"},{"key":"403_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"F Davatchi","year":"2014","unstructured":"Davatchi F, Assaad-Khalil S, Calamia KT, Crook JE, Sadeghi-Abdollahi B, Schirmer M, Tzellos T, Zouboulis CC, Akhlagi M, Al-Dalaan A, Alekberova ZS, Ali AA, Altenburg A, Arromdee E, Baltaci M, Bastos M, Benamour S, Ben Ghorbel I, Boyvat A, Carvalho L, Chen W, Ben-Chetrit E, Chams-Davatchi C, Correia JA, Crespo J, Dias C, Dong Y, Paix\u00e3o-Duarte F, Elmuntaser K, Elonakov AV, Gra\u00f1a Gil J, Haghdoost A-A, Hayani RM, Houman H, Isayeva AR, Jamshidi AR, Kaklamanis P, Kumar A, Kyrgidis A, Madanat W, Nadji A, Namba K, Ohno S, Olivieri I, Vaz Patto J, Pipitone N, De Queiroz MV, Ramos F, Resende C, Rosa CM, Salvarani C, Serra MJ, Shahram F, Shams H, Sharquie KE, Sliti-Khanfir M, Tribolet De Abreu T, Vasconcelos C, Vedes J, Wechsler B, Cheng YK, Zhang Z, Ziaei N. The International Criteria for Beh\u00e7et's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28:338\u201347.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"403_CR18","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/art.1780330811","volume":"33","author":"WP Arend","year":"1990","unstructured":"Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129\u201334.","journal-title":"Arthritis Rheum"},{"key":"403_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187\u201392.","journal-title":"Arthritis Rheum"},{"key":"403_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2144\/000114028","volume":"54","author":"X Yu","year":"2013","unstructured":"Yu X, Wallstrom G, Magee DM, Qiu J, Mendoza DE, Wang J, Bian X, Graves M, Labaer J. Quantifying antibody binding on protein microarrays using microarray nonlinear calibration. Biotechniques. 2013;54:257\u201364.","journal-title":"Biotechniques."},{"key":"403_CR21","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/1756-185X.13597","volume":"22","author":"IH Bassyouni","year":"2019","unstructured":"Bassyouni IH, Mohammed WHS, Taha FM, El Refai RM. Clinical significance of CCN2\/connective tissue growth factor in Behcet's disease patients. Int J Rheum Dis. 2019;22:1459\u201365.","journal-title":"Int J Rheum Dis"},{"key":"403_CR22","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.chest.2017.11.029","volume":"153","author":"Z Dong","year":"2018","unstructured":"Dong Z, Shi J, Dorhoi A, Zhang J, Soodeen-Lalloo AK, Tan W, Yin H, Sha W, Li W, Zheng R, Liu Z, Yang H, Qin L, Wang J, Huang X, Wu C, Kaufmann SHE, Feng Y. Hemostasis and lipoprotein indices signify exacerbated lung injury in TB with diabetes comorbidity. Chest. 2018;153:1187\u2013200.","journal-title":"Chest."},{"key":"403_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/13506129.2018.1474733","volume":"25","author":"S Erdogmus","year":"2018","unstructured":"Erdogmus S, Kendi Celebi Z, Akturk S, Kumru G, Duman N, Ates K, Erturk S, Nergizoglu G, Kutlay S, Sengul S, Keven K. Profile of renal AA amyloidosis in older and younger individuals: a single-Centre experience. Amyloid. 2018;25:115\u20139.","journal-title":"Amyloid."},{"key":"403_CR24","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/1756-185X.12529","volume":"18","author":"W Zheng","year":"2015","unstructured":"Zheng W, Li G, Zhou M, Chen L, Tian X, Zhang F. Renal involvement in Chinese patients with Behcet's disease: a report of 16 cases. Int J Rheum Dis. 2015;18:892\u20137.","journal-title":"Int J Rheum Dis"},{"key":"403_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/nyas.14003","volume":"1450","author":"CD Karakochuk","year":"2019","unstructured":"Karakochuk CD, Hess SY, Moorthy D, Namaste S, Parker ME, Rappaport AI, Wegmuller R, Dary O. Measurement and interpretation of hemoglobin concentration in clinical and field settings: a narrative review. Ann N Y Acad Sci. 2019;1450:126\u201346.","journal-title":"Ann N Y Acad Sci"},{"key":"403_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1055\/s-0035-1556727","volume":"41","author":"NV Butta","year":"2015","unstructured":"Butta NV, Fernandez-Bello I, Lopez-Longo FJ, Jimenez-Yuste V. Endothelial dysfunction and altered coagulation as mediators of thromboembolism in Behcet disease. Semin Thromb Hemost. 2015;41:621\u20138.","journal-title":"Semin Thromb Hemost"},{"key":"403_CR27","doi-asserted-by":"crossref","unstructured":"Stohl W, Kenol B, Kelly AJ, Ananth Correa A, Panush RS. Elevated serum globulin gap as a highly reliable marker of elevated erythrocyte sedimentation rate in patients with systemic rheumatic diseases. Semin Arthritis Rheum. 2019;49:485\u201392.","DOI":"10.1016\/j.semarthrit.2019.05.001"},{"key":"403_CR28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/ard.43.3.386","volume":"43","author":"M Helliwell","year":"1984","unstructured":"Helliwell M, Coombes EJ, Moody BJ, Batstone GF, Robertson JC. Nutritional status in patients with rheumatoid arthritis. Ann Rheum Dis. 1984;43:386\u201390.","journal-title":"Ann Rheum Dis"},{"key":"403_CR29","doi-asserted-by":"publisher","first-page":"1648072","DOI":"10.1155\/2019\/1648072","volume":"2019","author":"R Cehreli","year":"2019","unstructured":"Cehreli R, Yavuzsen T, Ates H, Akman T, Ellidokuz H, Oztop I. Can inflammatory and nutritional serum markers predict chemotherapy outcomes and survival in advanced stage nonsmall cell lung Cancer patients? Biomed Res Int. 2019;2019:1648072.","journal-title":"Biomed Res Int"},{"key":"403_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/000313481408000129","volume":"80","author":"Z Xu","year":"2014","unstructured":"Xu Z, Li Y, Yang X, Wang J, Li J. Early detection of coagulation abnormalities in patients at nutritional risk: the novel role of thromboelastography. Am Surg. 2014;80:81\u20136.","journal-title":"Am Surg"},{"key":"403_CR31","doi-asserted-by":"publisher","first-page":"11583","DOI":"10.1038\/s41598-019-48189-y","volume":"9","author":"W Wang","year":"2019","unstructured":"Wang W, Ren D, Wang CS, Li T, Yao HC. High sensitivity C-reactive protein to prealbumin ratio measurement as a marker of the prognosis in acute coronary syndrome. Sci Rep. 2019;9:11583.","journal-title":"Sci Rep"},{"key":"403_CR32","volume-title":"Physiology, acute phase reactants. StatPearls","author":"R Gulhar","year":"2019","unstructured":"Gulhar R, Jialal I. Physiology, acute phase reactants. StatPearls. Treasure Island (FL): StatPearls Publishing StatPearls Publishing LLC; 2019."},{"key":"403_CR33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/rheumatology\/38.8.747","volume":"38","author":"D Niethammer","year":"1999","unstructured":"Niethammer D, K\u00fcMmerle-Deschner J, Dannecker GE. Side-effects of long-term immunosuppression versus morbidity in autologous stem cell rescue: striking the balance. Rheumatology. 1999;38:747\u201350.","journal-title":"Rheumatology."},{"key":"403_CR34","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/0167-5699(93)90053-N","volume":"14","author":"J-F Bach","year":"1993","unstructured":"Bach J-F. Immunosuppressive therapy of autoimmune diseases. Immunol Today. 1993;14:322\u20136.","journal-title":"Immunol Today"},{"key":"403_CR35","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1006\/rwei.1999.0344","volume-title":"Encyclopedia of Immunology (Second Edition)","author":"JF Borel","year":"1998","unstructured":"Borel JF. Immunosuppression. In: Delves PJ, editor. Encyclopedia of Immunology (Second Edition). Oxford: Elsevier; 1998. p. 1349\u201353."},{"key":"403_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0753-3322(01)00154-8","volume":"56","author":"LPC Shek","year":"2002","unstructured":"Shek LPC, Lim DLC. Thalidomide in Beh\u00e7et\u2019s disease. Biomed Pharmacother. 2002;56:31\u20135.","journal-title":"Biomed Pharmacother"},{"key":"403_CR37","unstructured":"A General Review of the Mechanisms for Steroid or Glucocorticoid Induced Increases in the White Blood Cell (WBC) Count. EVIDENCE-BASED MEDICINE CONSULT. Available from: https:\/\/www.ebmconsult.com\/articles\/steroids-glucocorticoids-wbc-neutrophiles-increase. Accessed 15 Nov 2020."},{"key":"403_CR38","doi-asserted-by":"crossref","unstructured":"Ronchetti S, Ricci E, Migliorati G, Gentili M, Riccardi C. How glucocorticoids affect the neutrophil life. Int J Mol Sci. 2018;19:4090.","DOI":"10.3390\/ijms19124090"},{"key":"403_CR39","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.3389\/fimmu.2018.03143","volume":"9","author":"LM Ince","year":"2018","unstructured":"Ince LM, Weber J, Scheiermann C. Control of leukocyte trafficking by stress-associated hormones. Front Immunol. 2018;9:3143.","journal-title":"Front Immunol"},{"key":"403_CR40","first-page":"119s","volume":"11","author":"DI Min","year":"1991","unstructured":"Min DI, Monaco AP. Complications associated with immunosuppressive therapy and their management. Pharmacotherapy. 1991;11:119s\u201325s.","journal-title":"Pharmacotherapy"},{"key":"403_CR41","first-page":"234","volume":"21","author":"H Atas","year":"2018","unstructured":"Atas H, Canpolat F, Eskioglu F. Evaluation of mean platelet volume in patients with Behcet's disease as an Indicator of vascular thrombosis. Arch Iran Med. 2018;21:234\u20139.","journal-title":"Arch Iran Med."},{"key":"403_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2020.04.018","volume":"307","author":"WC Schrottmaier","year":"2020","unstructured":"Schrottmaier WC, Mussbacher M, Salzmann M, Assinger A. Platelet-leukocyte interplay during vascular disease. Atherosclerosis. 2020;307:109\u201320.","journal-title":"Atherosclerosis."},{"key":"403_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1620\/tjem.221.119","volume":"221","author":"N Acikgoz","year":"2010","unstructured":"Acikgoz N, Karincaoglu Y, Ermis N, Yagmur J, Atas H, Kurtoglu E, Cansel M, Barutcu I, Pekdemir H, Ozdemir R. Increased mean platelet volume in Behcet's disease with thrombotic tendency. Tohoku J Exp Med. 2010;221:119\u201323.","journal-title":"Tohoku J Exp Med"},{"key":"403_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/0953710031000137055","volume":"14","author":"IA Jagroop","year":"2003","unstructured":"Jagroop IA, Tsiara S, Mikhailidis DP. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets. 2003;14:335\u20136.","journal-title":"Platelets."},{"key":"403_CR45","doi-asserted-by":"crossref","unstructured":"Pamuk GE, Pamuk ON, Or\u00fcm H, Demir M, Turgut B, Cakir N. Might platelet-leucocyte complexes be playing a role in major vascular involvement of Beh\u00e7et's disease? A comparative study. Blood Coagul Fibrinolysis. 2010;21:113\u20137.","DOI":"10.1097\/MBC.0b013e328330bdc4"},{"key":"403_CR46","unstructured":"Demir Pektas S, Alatas E, Yilmaz N. Plateletcrit is potential biomarker for presence and severity of psoriasis vulgaris. Acta Medica Mediterranea. 2016; 32:1785."},{"key":"403_CR47","first-page":"234","volume":"21","author":"H Ata\u015f","year":"2018","unstructured":"Ata\u015f H, Canpolat F, Eskioglu F. Evaluation of mean platelet volume in patients with Behcet&rsquo;s disease as an Indicator of vascular thrombosis. Arch Iran Med. 2018;21:234\u20139.","journal-title":"Arch Iran Med"},{"key":"403_CR48","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/rheumatology\/35.5.424","volume":"35","author":"S Sahin","year":"1996","unstructured":"Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Ako\u011flu T. Monocyte activity in Behcet's disease. Br J Rheumatol. 1996;35:424\u20139.","journal-title":"Br J Rheumatol"},{"key":"403_CR49","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1182\/blood-2013-11-462432","volume":"123","author":"CN Morrell","year":"2014","unstructured":"Morrell CN, Aggrey AA, Chapman LM, Modjeski KL. Emerging roles for platelets as immune and inflammatory cells. Blood. 2014;123:2759\u201367.","journal-title":"Blood."},{"key":"403_CR50","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/1074248415609436","volume":"21","author":"N Glezeva","year":"2016","unstructured":"Glezeva N, Gilmer JF, Watson CJ, Ledwidge M. A central role for monocyte-platelet interactions in heart failure. J Cardiovasc Pharmacol Ther. 2016;21:245\u201361.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"403_CR51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000444807","volume":"43","author":"JB Kral","year":"2016","unstructured":"Kral JB, Schrottmaier WC, Salzmann M, Assinger A. Platelet interaction with innate immune cells. Transfus Med Hemother. 2016;43:78\u201388.","journal-title":"Transfus Med Hemother"},{"key":"403_CR52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jnma.2019.01.010","volume":"111","author":"J-F Ye","year":"2019","unstructured":"Ye J-F, Chen Y, Cai J-F, Shen Y, Zou J, Guan J-L. Incidence and risk factors for anemia among newly-diagnosed intestinal Behcet's disease patients. J Natl Med Assoc. 2019;111:407\u201312.","journal-title":"J Natl Med Assoc"},{"key":"403_CR53","first-page":"121","volume":"41","author":"D \u00c7i\u00e7ek","year":"2007","unstructured":"\u00c7i\u00e7ek D, Kandi B, \u0130lhan N, Bakar Dertlio\u011flu S, Demir B. Frequency of Anemia of Chronic Disease in Patients with Behcet\u00eds Disease. TURKDERM - Turkish Arch Dermatol Venereol. 2007;41:121\u20134.","journal-title":"TURKDERM - Turkish Arch Dermatol Venereol"},{"key":"403_CR54","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/rheumatology\/ken162","volume":"47","author":"JK Ahn","year":"2008","unstructured":"Ahn JK, Cha HS, Koh EM, Kim SH, Kim YG, Lee CK, Yoo B. Behcet's disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology. 2008;47:1228\u201330.","journal-title":"Rheumatology."},{"key":"403_CR55","first-page":"22","volume-title":"UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi","author":"M Dagl\u0131","year":"2012","unstructured":"Dagl\u0131 M, Yilmaz S, Sivrikaya A, Celik G. The role of Prohepcidin and Hepcidin in Anemia associated with Beh\u00e7et's disease. In: UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi; 2012. p. 22."}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-021-00403-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12865-021-00403-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-021-00403-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T18:59:18Z","timestamp":1697914758000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-021-00403-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["403"],"URL":"https:\/\/doi.org\/10.1186\/s12865-021-00403-1","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Medical Ethics Committee of Peking Union Medical College Hospital. This manuscript does not contain data for any individual person.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}